Actively Recruiting
Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry
Led by Lille University · Updated on 2025-04-11
20
Participants Needed
1
Research Sites
50 weeks
Total Duration
On this page
Sponsors
L
Lille University
Lead Sponsor
C
Centre Oscar Lambret, Lille, France
Collaborating Sponsor
AI-Summary
What this Trial Is About
This non-interventional study aims to develop spatial proteomics for analyzing small FFPE tumor samples in rhabdomyosarcoma. It will identify molecular signatures linked to tumor regions, subtypes, survival, and treatment resistance, using pre-existing samples and data.
CONDITIONS
Official Title
Identification of Specific Molecular Signatures in Pediatric, Adolescent, and Young Adult Rhabdomyosarcoma Through Spatial Proteome Analysis Using Mass Spectrometry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 0 and 25 years at the time of initial diagnosis
- Histologically confirmed diagnosis of rhabdomyosarcoma
- Received care at the Oscar Lambret Center between January 2005 and November 2024
- No objection to the use of data and biological samples collected during care for research purposes
You will not qualify if you...
- No available biological sample in FFPE from biopsy or surgical specimen at the Oscar Lambret Center
- Patient is under guardianship or trusteeship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oscar Lambret Center
Lille, Nord, France, 59000
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here